聚乙二醇干扰素最初联合拉米夫定或阿德福韦治疗hbeag阳性慢性乙型肝炎的疗效:一项系统评价和荟萃分析

{"title":"聚乙二醇干扰素最初联合拉米夫定或阿德福韦治疗hbeag阳性慢性乙型肝炎的疗效:一项系统评价和荟萃分析","authors":"B. Chen, Jin Li, Xu Feng, Yun Zhang, S. Song, M. Liu, Zhong-fu Zhao","doi":"10.7507/1672-2531.20160016","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":39892,"journal":{"name":"中国循证医学杂志","volume":"16 1","pages":"79-86"},"PeriodicalIF":0.0000,"publicationDate":"2016-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Efficacy of peginterferon alpha initially combined with lamivudine or adefovir in treatment of HBeAg-positive Chronic Hepatitis B: A systematic review and meta-analysis\",\"authors\":\"B. Chen, Jin Li, Xu Feng, Yun Zhang, S. Song, M. Liu, Zhong-fu Zhao\",\"doi\":\"10.7507/1672-2531.20160016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":39892,\"journal\":{\"name\":\"中国循证医学杂志\",\"volume\":\"16 1\",\"pages\":\"79-86\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国循证医学杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.7507/1672-2531.20160016\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国循证医学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7507/1672-2531.20160016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}